Literature DB >> 10648187

Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase.

C Logvinoff1, A L Epstein.   

Abstract

The prokaryotic Cre-loxP recombination system is a powerful tool that enables in vitro and in vivo site-specific manipulations of the genome of eukaryotic cells as well as of DNA viruses and their derived vectors. This system, however, has not yet been exploited in the context of herpes simplex virus type 1 (HSV-1) infected cells, perhaps because this virus encodes several functions that induce a strong shutoff of cellular protein synthesis, a fact that could preclude expression of cellular-encoded Cre recombinase. In the present study, we show that efficient site-specific recombination can take place in cell lines expressing Cre, even in the context of HSV-1 infection, as evidenced by the engineering of an HSV-1 recombinant virus and several viral vectors carrying one or two loxP sequences. More precisely, we have used this system to induce an irreversible switch in the expression of a viral complex transcription unit encoding two different open reading frames and allowing consecutive expression of two reporter genes. Furthermore Cre recombinations were also used to induce the decatenation of the genomic concatemers harbored by amplicon particles upon infection of cells under nonreplicative conditions, thus enabling the rescue of many independent plasmids corresponding to the original amplicon plasmid used to generate the vectors. Thus the Cre-loxP recombination system can successfully be used for engineering the genome of HSV-1 or HSV-1-based vectors in cultured cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648187     DOI: 10.1006/viro.1999.0108

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Intracellular Cre-mediated deletion of the unique packaging signal carried by a herpes simplex virus type 1 recombinant and its relationship to the cleavage-packaging process.

Authors:  C Logvinoff; A L Epstein
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Gene transfer of NMDAR1 subunit sequences to the rat CNS using herpes simplex virus vectors interfered with habituation.

Authors:  V T Cheli; M F Adrover; C Blanco; E Rial Verde; V Guyot-Revol; R Vidal; E Martin; L Alché; G Sanchez; M Acerbo; A L Epstein; D Jerusalinsky
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

3.  Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice.

Authors:  Rachel D Penrod; Audrey M Wells; William A Carlezon; Christopher W Cowan
Journal:  Curr Protoc Neurosci       Date:  2015-10-01

4.  Determination of minimum herpes simplex virus type 1 components necessary to localize transcriptionally active DNA to ND10.

Authors:  Qiyi Tang; Luge Li; Alexander M Ishov; Valerie Revol; Alberto L Epstein; Gerd G Maul
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectors.

Authors:  Sabine Schenck; Elke Kehm; Alberto L Epstein; Hanswalter Zentgraf; Martin Müller; Charles W Knopf
Journal:  Virus Genes       Date:  2008-06-12       Impact factor: 2.332

6.  Nuclear domain 10-associated proteins recognize and segregate intranuclear DNA/protein complexes to negate gene expression.

Authors:  Yisel A Rivera-Molina; Bruno R Rojas; Qiyi Tang
Journal:  Virol J       Date:  2012-09-28       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.